246 related articles for article (PubMed ID: 33166742)
1. Interaction between magnesium and methylglyoxal in diabetic polyneuropathy and neuronal models.
Strom A; Strassburger K; Schmuck M; Shevalye H; Davidson E; Zivehe F; Bönhof G; Reimer R; Belgardt BF; Fleming T; Biermann B; Burkart V; Müssig K; Szendroedi J; Yorek MA; Fritsche E; Nawroth PP; Roden M; Ziegler D;
Mol Metab; 2021 Jan; 43():101114. PubMed ID: 33166742
[TBL] [Abstract][Full Text] [Related]
2. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
[TBL] [Abstract][Full Text] [Related]
3. Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells--protection by carbonyl scavengers.
de Arriba SG; Stuchbury G; Yarin J; Burnell J; Loske C; Münch G
Neurobiol Aging; 2007 Jul; 28(7):1044-50. PubMed ID: 16781798
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes.
Aghanoori MR; Smith DR; Shariati-Ievari S; Ajisebutu A; Nguyen A; Desmond F; Jesus CHA; Zhou X; Calcutt NA; Aliani M; Fernyhough P
Mol Metab; 2019 Feb; 20():149-165. PubMed ID: 30545741
[TBL] [Abstract][Full Text] [Related]
5. (+)-Catechin mitigates impairment in insulin secretion and beta cell damage in methylglyoxal-induced pancreatic beta cells.
Anaga N; Lekshmy K; Purushothaman J
Mol Biol Rep; 2024 Mar; 51(1):434. PubMed ID: 38520585
[TBL] [Abstract][Full Text] [Related]
6. Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy?
Engelen W; Bouten A; De Leeuw I; De Block C
Magnes Res; 2000 Sep; 13(3):197-203. PubMed ID: 11008927
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of p53 and Parkin Induce Mitochondrial Dysfunction and Leads to the Diabetic Neuropathic Pain.
Yamashita A; Matsuoka Y; Matsuda M; Kawai K; Sawa T; Amaya F
Neuroscience; 2019 Sep; 416():9-19. PubMed ID: 31377450
[TBL] [Abstract][Full Text] [Related]
8. Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels.
Huang Q; Chen Y; Gong N; Wang YX
Metabolism; 2016 Apr; 65(4):463-74. PubMed ID: 26975538
[TBL] [Abstract][Full Text] [Related]
9. Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies.
Shamsaldeen YA; Mackenzie LS; Lione LA; Benham CD
Curr Drug Metab; 2016; 17(4):359-67. PubMed ID: 26965039
[TBL] [Abstract][Full Text] [Related]
10. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.
Perkins BA; Grewal J; Ng E; Ngo M; Bril V
Diabetes Care; 2006 Sep; 29(9):2023-7. PubMed ID: 16936147
[TBL] [Abstract][Full Text] [Related]
11. Ranirestat Improved Nerve Conduction Velocities, Sensory Perception, and Intraepidermal Nerve Fiber Density in Rats with Overt Diabetic Polyneuropathy.
Asano S; Himeno T; Hayami T; Motegi M; Inoue R; Nakai-Shimoda H; Miura-Yura E; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Kato K; Naruse K; Nakamura J; Kamiya H
J Diabetes Res; 2019; 2019():2756020. PubMed ID: 31828158
[TBL] [Abstract][Full Text] [Related]
12. Glucagon Prevents Cytotoxicity Induced by Methylglyoxal in a Rat Neuronal Cell Line Model.
Mohiuddin MS; Himeno T; Yamada Y; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Nakamura J; Kamiya H
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672050
[TBL] [Abstract][Full Text] [Related]
13. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
[TBL] [Abstract][Full Text] [Related]
14. Methylglyoxal, diabetes mellitus and diabetic complications.
Vander Jagt DL
Drug Metabol Drug Interact; 2008; 23(1-2):93-124. PubMed ID: 18533366
[TBL] [Abstract][Full Text] [Related]
15. Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing Links.
Groener JB; Oikonomou D; Cheko R; Kender Z; Zemva J; Kihm L; Muckenthaler M; Peters V; Fleming T; Kopf S; Nawroth PP
Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):497-504. PubMed ID: 28407670
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy.
Chandrasekaran K; Salimian M; Konduru SR; Choi J; Kumar P; Long A; Klimova N; Ho CY; Kristian T; Russell JW
Brain; 2019 Dec; 142(12):3737-3752. PubMed ID: 31754701
[TBL] [Abstract][Full Text] [Related]
17. Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey.
Davies JL; Lodermeier KA; Klein DM; Carter RE; Dyck PJB; Litchy WJ; Dyck PJ
Muscle Nerve; 2023 Jul; 68(1):29-38. PubMed ID: 36734298
[TBL] [Abstract][Full Text] [Related]
18. Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.
Pittenger GL; Malik RA; Burcus N; Boulton AJ; Vinik AI
Diabetes Care; 1999 Nov; 22(11):1839-44. PubMed ID: 10546017
[TBL] [Abstract][Full Text] [Related]
19. Activation of Nrf2 attenuates carbonyl stress induced by methylglyoxal in human neuroblastoma cells: Increase in GSH levels is a critical event for the detoxification mechanism.
Nishimoto S; Koike S; Inoue N; Suzuki T; Ogasawara Y
Biochem Biophys Res Commun; 2017 Feb; 483(2):874-879. PubMed ID: 28073699
[TBL] [Abstract][Full Text] [Related]
20. Association of transketolase polymorphisms with measures of polyneuropathy in patients with recently diagnosed diabetes.
Ziegler D; Schleicher E; Strom A; Knebel B; Fleming T; Nawroth P; Häring HU; Papanas N; Szendrödi J; Müssig K; Al-Hasani H; Roden M;
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 27103086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
